Literature DB >> 36253542

MiR-330-5p and miR-1270 target essential components of RNA polymerase I transcription and exhibit a novel tumor suppressor role in lung adenocarcinoma.

Sheetanshu Saproo1, Shashanka S Sarkar1, Ekta Gupta1, Sourav Chattopadhyay1, Aarzoo Charaya1, Siddhant Kalra2, Gaurav Ahuja2, Srivatsava Naidu3.   

Abstract

Upregulation of RNA polymerase I (Pol I) transcription and the overexpression of Pol I transcriptional machinery are crucial molecular alterations favoring malignant transformation. However, the causal molecular mechanism(s) of this aberration remain largely unknown. Here, we found that Pol I transcription and its core machinery are upregulated in lung adenocarcinoma (LUAD). We show that the loss of miRNAs (miR)-330-5p and miR-1270 expression contributes to the upregulation of Pol I transcription in LUAD. Constitutive overexpression of these miRs in LUAD cell lines suppressed the expression of core components of Pol I transcription, and reduced global ribosomal RNA synthesis. Importantly, miR-330-5p/miR-1270-mediated repression of Pol I transcription exerted multiple tumor suppressive functions including reduced proliferation, cell cycle arrest, enhanced apoptosis, reduced migration, increased drug sensitivity, and reduced tumor burden in a mouse xenograft model. Mechanistically, the downregulation of miR-330-5p and miR-1270 is regulated by Pol I subunit-derived circular RNA circ_0055467 and DNA hypermethylation, respectively. This study uncovers a novel miR-330-5p/miR-1270 mediated post-transcriptional regulation of Pol I transcription, and establish tumor suppressor properties of these miRs in LUAD. Ultimately, our findings provide a rationale for the therapeutic targeting of Pol I transcriptional machinery for LUAD.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2022        PMID: 36253542     DOI: 10.1038/s41417-022-00544-4

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.854


  44 in total

Review 1.  Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus.

Authors:  Ingrid Grummt
Journal:  Genes Dev       Date:  2003-07-15       Impact factor: 11.361

Review 2.  Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases.

Authors:  C Mayer; I Grummt
Journal:  Oncogene       Date:  2006-10-16       Impact factor: 9.867

3.  Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.

Authors:  Stefano Rossetti; Andrzej J Wierzbicki; Nicoletta Sacchi
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

4.  Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis.

Authors:  S P Bell; R M Learned; H M Jantzen; R Tjian
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

5.  hRRN3 is essential in the SL1-mediated recruitment of RNA Polymerase I to rRNA gene promoters.

Authors:  G Miller; K I Panov; J K Friedrich; L Trinkle-Mulcahy; A I Lamond; J C Zomerdijk
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 6.  RNA polymerases I and III, growth control and cancer.

Authors:  Robert J White
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

Review 7.  Does the ribosome translate cancer?

Authors:  Davide Ruggero; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

Review 8.  Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes.

Authors:  Sarah J Goodfellow; Joost C B M Zomerdijk
Journal:  Subcell Biochem       Date:  2013

9.  Loss of m1acp3Ψ Ribosomal RNA Modification Is a Major Feature of Cancer.

Authors:  Artem Babaian; Katharina Rothe; Dylan Girodat; Igor Minia; Sara Djondovic; Miha Milek; Sandra E Spencer Miko; Hans-Joachim Wieden; Markus Landthaler; Gregg B Morin; Dixie L Mager
Journal:  Cell Rep       Date:  2020-05-05       Impact factor: 9.423

10.  Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.

Authors:  Megan J Bywater; Gretchen Poortinga; Elaine Sanij; Nadine Hein; Abigail Peck; Carleen Cullinane; Meaghan Wall; Leonie Cluse; Denis Drygin; Kenna Anderes; Nanni Huser; Chris Proffitt; Joshua Bliesath; Mustapha Haddach; Michael K Schwaebe; David M Ryckman; William G Rice; Clemens Schmitt; Scott W Lowe; Ricky W Johnstone; Richard B Pearson; Grant A McArthur; Ross D Hannan
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.